Literature DB >> 4227319

Effects of 5-trifluoromethyldeoxyuridine upon deoxythymidine kinase.

E Bresnick, S S Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4227319     DOI： 10.1016/0006-2952(67)90097-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Mamoru Nukatsuka; Masakazu Fukushima
Journal:  Exp Ther Med       Date:  2011-03-21       Impact factor: 2.447

2.  Biological effects of 5-carboxy-2'-deoxyuridine: hydrolysis product of 5-trifluoromethyl-2'-deoxyuridine.

Authors:  D W Clough; B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

3.  Inhibition of mouse LM cell replication by trifluorothymidine: role of cytosolic deoxythymidine kinase.

Authors:  B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 4.  TAS-102: a novel antimetabolite for the 21st century.

Authors:  Nataliya Uboha; Howard S Hochster
Journal:  Future Oncol       Date:  2015-11-30       Impact factor: 3.404

5.  Inhibition of human cytomegalovirus by trifluorothymidine.

Authors:  S A Spector; M Tyndall; E Kelley
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

6.  Experimental herpes simplex virus type 1 encephalitis: treatment with 5-trifluoromethyl-2'-deoxyuridine.

Authors:  D W Clough; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

7.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

Review 8.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

9.  Activity of trifluorothymidine against cytomegalovirus.

Authors:  J R Wingard; R K Stuart; R Saral; W H Burns
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

10.  Potentiation of the antitumor activity of 5-trifluoromethyl-2'-deoxyuridine by the use of depot forms of the parent compound.

Authors:  S Takeda; K Wierzba; J Yamashita; H Matsumoto; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.